Yonsei Med J.  2016 Nov;57(6):1370-1375. 10.3349/ymj.2016.57.6.1370.

Prevalence and Risk Factors of Gallbladder Polypoid Lesions in a Healthy Population

• Choi YS
• Do JH
• Seo SW
• Lee SE
• Oh HC
• Min YJ
• Kang H

• KMID: 2427154
• DOI: http://doi.org/10.3349/ymj.2016.57.6.1370

Abstract

PURPOSE
To determine the prevalence of and investigate the risk factors for gallbladder (GB) polypoid lesions in a healthy population.
MATERIALS AND METHODS
A total of 23827 subjects who underwent abdominal ultrasonography in conjunction with health screening examinations were retrospectively analyzed. The prevalence of risk factors for GB polypoid lesions were evaluated. In addition, risk factors according to the number of polypoid lesions and the presence of stones with polypoid lesions were investigated. To analyze these risk factors, a control group was established with a 1:2 ratio matched for age and sex.
RESULTS
The prevalence of GB polypoid lesions was identified as 9.96%. On multivariate analysis, chronic hepatitis B infection (CHB) and the presence of metabolic syndrome (MS) were risk factors for GB polypoid lesions. CHB and MS were also significant independent risk factors for multiple GB polypoid lesions when compared with solitary GB polypoid lesions. In addition, gastric Helicobacter pylori infection and MS were significant risk factors for GB polypoid lesions with stones when compared with GB polypoid lesions without stones.
CONCLUSION
The prevalence of GB polypoid lesions in a healthy Korean population was 9.96%. Patients with CHB and MS need to be carefully examined for such lesions.

Keyword

Gallbladder; polypoid lesion; prevalence; risk factor; chronic hepatitis B

MeSH Terms

Adult
Aged
Aged, 80 and over
Case-Control Studies
Female
Gallbladder Diseases/*diagnostic imaging/*epidemiology
Hepatitis B, Chronic/epidemiology
Humans
Male
Metabolic Syndrome/epidemiology
Middle Aged
Polyps/*diagnostic imaging/*epidemiology
Prevalence
Retrospective Studies
Risk Factors
Ultrasonography/*methods

Reference

1. Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol. 1970; 90:423–432.

2. Aldridge MC, Bismuth H. Gallbladder cancer: the polyp-cancer sequence. Br J Surg. 1990; 77:363–364.

3. Lee KF, Wong J, Li JC, Lai PB. Polypoid lesions of the gallbladder. Am J Surg. 2004; 188:186–190.

4. Lin WR, Lin DY, Tai DI, Hsieh SY, Lin CY, Sheen IS, et al. Prevalence of and risk factors for gallbladder polyps detected by ultrasonography among healthy Chinese: analysis of 34 669 cases. J Gastroenterol Hepatol. 2008; 23:965–969.

5. Jørgensen T, Jensen KH. Polyps in the gallbladder. A prevalence study. Scand J Gastroenterol. 1990; 25:281–286.

6. Segawa K, Arisawa T, Niwa Y, Suzuki T, Tsukamoto Y, Goto H, et al. Prevalence of gallbladder polyps among apparently healthy Japanese: ultrasonographic study. Am J Gastroenterol. 1992; 87:630–633.

7. Chen CY, Lu CL, Chang FY, Lee SD. Risk factors for gallbladder polyps in the Chinese population. Am J Gastroenterol. 1997; 92:2066–2068.

8. Kim SY, Lee HS, Lee YS, Chung KW, Jang BK, Chung WJ, et al. Prevalence and risk factors of gallbladder polyp in adults living in Daegu and Gyeongbuk provinces. Korean J Gastroenterol. 2006; 48:344–350.

9. Lim SH, Kim DH, Park MJ, Kim YS, Kim CH, Yim JY, et al. Is metabolic syndrome one of the risk factors for gallbladder polyps found by ultrasonography during health screening? Gut Liver. 2007; 1:138–144.

10. Myers RP, Shaffer EA, Beck PL. Gallbladder polyps: epidemiology, natural history and management. Can J Gastroenterol. 2002; 16:187–194.

11. Western Pacific Regional Office of the World Health Organization, The International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia;2000.

12. Shim SG, Lee KT, Lee JK, Park JH, Ryu JH, Rhee PL, et al. Prevalence and risk factors of gallbladder polyps in health screening subjects. Korean J Med. 1999; 57:1014–1020.

13. Lee YJ, Park KS, Cho KB, Kim ES, Jang BK, Chung WJ, et al. Shifting prevalence of gallbladder polyps in Korea. J Korean Med Sci. 2014; 29:1247–1252.

14. Hong AR, Lim S. Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries. J Diabetes Investig. 2015; 6:508–515.

15. Collett JA, Allan RB, Chisholm RJ, Wilson IR, Burt MJ, Chapman BA. Gallbladder polyps: prospective study. J Ultrasound Med. 1998; 17:207–211.

16. Braghetto I, Antezana C, Hurtado C, Csendes A. Triglyceride and cholesterol content in bile, blood, and gallbladder wall. Am J Surg. 1988; 156:26–28.

17. Everson GT. Gallbladder function in gallstone disease. Gastroenterol Clin North Am. 1991; 20:85–110.

18. Lim S, Park KS, Lee HK, Cho SI. Korean National Health and Nutrition Examination Surveys. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care. 2005; 28:1810–1812.

19. Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000; 95:1402–1410.

20. Koga A, Watanabe K, Fukuyama T, Takiguchi S, Nakayama F. Diagnosis and operative indications for polypoid lesions of the gallbladder. Arch Surg. 1988; 123:26–29.

21. Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care. 2012; 35:2402–2411.

22. Borena W, Edlinger M, Bjørge T, Häggström C, Lindkvist B, Nagel G, et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One. 2014; 9:e89368.

23. Takahashi Y, Yamamichi N, Shimamoto T, Mochizuki S, Fujishiro M, Takeuchi C, et al. Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan. J Gastroenterol. 2014; 49:882–889.

24. Mishra RR, Tewari M, Shukla HS. Association of Helicobacter pylori infection with inflammatory cytokine expression in patients with gallbladder cancer. Indian J Gastroenterol. 2013; 32:232–235.

25. Murphy G, Michel A, Taylor PR, Albanes D, Weinstein SJ, Virtamo J, et al. Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. Hepatology. 2014; 60:1963–1971.

26. Hassan EH, Gerges SS, El-Atrebi KA, El-Bassyouni HT. The role of H. pylori infection in gall bladder cancer: clinicopathological study. Tumour Biol. 2015; 36:7093–7098.